CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT(3-4a)N(0-1)M(0)) (NCT03001596)

BACKGROUND: Neoadjuvant chemoradiation is not recommended as an approach for treatment of esophageal squamous cell carcinoma due to its significant postoperative mortality. However, it is assumed the combination of neoadjuvant chemoradiation with minimally invasive esophagectomy (MIE) may reduce pos...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Main Authors: Tang, Han, Tan, Lijie, Shen, Yaxing, Wang, Hao, Lin, Miao, Feng, Mingxiang, Xu, Songtao, Guo, Weigang, Qian, Cheng, Liu, Tianshu, Zeng, Zhaochong, Hou, Yingyong, Yu, Zhentao, Jiang, Hongjing, Li, Zhigang, Chen, Chun, Lian, Changhong, Du, Ming, Li, Hecheng, Xie, Deyao, Yin, Jun, Zhao, Naiqing, Wang, Qun
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2017
Assuntos:
Study Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5490174/
https://ncbi.nlm.nih.gov/pubmed/28659128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3446-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares